Comparison of treatment strategies for resectable locally advanced primary mucinous adenocarcinoma of the lung.

ABSTRACT: Primary pure mucinous adenocarcinoma (PMA) is a rare type of lung cancer with unique clinical and prognostic features. Previous studies have shown that PMA have more early-stage cancer compared with other adenocarcinoma (ADC) subtypes. The clinicopathological features and optimal treatment strategies of resectable locally advanced mucinous adenocarcinoma lack evidence and require further study. In this study, we collected information from patients with stage III-N2 PMA who underwent radical surgery between 2004 and 2016 from the Surveillance, Epidemiology, and End Results (SEER) database. The clinicopathological parameters, treatments, overall survival (OS), and cancer-specific survival (CSS) were evaluated. Of 242,699 eligible lung adenocarcinoma patients, 124 with PMA and 3405 with other

SUBMITTER: Gu Y 

PROVIDER: S-EPMC10166977 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature